RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Cutaneous Neuroendocrine Carcinoma: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Outcomes of curative treatment for non-Merkel cell polyomavirus associated stage I-III Merkel cell carcinoma: a retrospective real world cohort study
Daniel Xing, European Society of Radiology (19 October 2026)
https://doi.org/10.26044/ranzcr2026/c-340
- 2.
Demographic, socioeconomic, and geographic predictors of treatment utilization and survival in Merkel cell carcinoma: an analysis of the national cancer database
Julia K. Russolillo et al., Archives of Dermatological Research (15 October 2026)
https://doi.org/10.1007/s00403-026-04985-x
- 3.
The Deadly Merkel Cell Carcinoma Escapes Apoptosis but Not Ferroptosis
Mandlin Abdulaziz Almousa et al., Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (15 October 2026)
https://doi.org/10.1016/j.oooo.2026.08.049
- 4.
Immunohistochemical Analysis of INSM1, MCPyV, and PHOX2B Expression in Merkel Cell Carcinoma.
Noyan Mod Beste et al., The American Journal of dermatopathology (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42878623/
- 5.
Management of Merkel Cell Carcinoma of the Digits, Hand, and Wrist.
Raman Karanvir S et al., Plastic surgery (Oakville, Ont.) (13 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42876867/
Clinical Trials : Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
NCT07115043 · Recruiting · Phase 1 / Phase 2 · AstraZeneca
Ages 18 and over
https://clinicaltrials.gov/study/NCT07115043
- 2.
Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma
NCT06151236 · Recruiting · Phase 2 · Melanoma Institute Australia
Ages 18 and over
https://clinicaltrials.gov/study/NCT06151236
- 3.
A Beta-only IL-2 ImmunoTherapY Study
NCT05086692 · Recruiting · Phase 1 / Phase 2 · Medicenna Therapeutics, Inc.
Ages 18 and over
https://clinicaltrials.gov/study/NCT05086692
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Cutaneous Neuroendocrine Carcinoma
Merkel cell carcinoma is a rare and aggressive skin cancer that usually appears as a firm, painless lump on sun-exposed skin. It often affects older people and those with weakened immune systems. Treatment usually involves surgery and radiotherapy, and immunotherapy medicines are used for advanced disease. Research continues into the role of the Merkel cell polyomavirus and sun damage.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Cutaneous Neuroendocrine Carcinoma?
Merkel cell carcinoma is a rare and aggressive skin cancer that usually appears as a firm, painless lump on sun-exposed skin. It often affects older people and those with weakened immune systems. Treatment usually involves surgery and radiotherapy, and immunotherapy medicines are used for advanced disease. Research continues into the role of the Merkel cell polyomavirus and sun damage.
How many clinical trials are available for Cutaneous Neuroendocrine Carcinoma?
RareWays currently indexes 127 clinical trials for Cutaneous Neuroendocrine Carcinoma, of which 28 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Cutaneous Neuroendocrine Carcinoma come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Cutaneous Neuroendocrine Carcinoma.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.